Medical technology company in Sheffield appoints new UK managing director

Medical technology company B Braun Medical has appointed a new UK managing director.

Michael Parden has been appointed to the role, having worked for the Sheffield-headquartered B. Braun Group for more than 20 years.

Mr Parden, 47, who lives with his family in Sheffield, first joined the B Braun Group in 2001 when he joined the Aesculap manufacturing and technical services division.

Hide Ad
Hide Ad

He then assumed the role of operations manager at B. Braun Sterilog in 2010 and became the company's managing director in 2013. In 2018, he became the division manager for B Braun's Aesculap business division and took over the responsibility for the B Braun compounding aseptic unit in 2021.

Michael Parden, managing director of B Braun Medical. Picture: Patrick JT BannonMichael Parden, managing director of B Braun Medical. Picture: Patrick JT Bannon
Michael Parden, managing director of B Braun Medical. Picture: Patrick JT Bannon

Mr Parden said: “To have been given the opportunity to lead this great company, which employs over 1400 people in the UK, is one that I am immensely proud of.

“Becoming managing director of B Braun UK was always a huge ambition of mine having spent over 20 years working for the company, so naturally I am absolutely delighted to have been appointed to my new role.

He added: “My vision is for the company to be seen as a flagship employer in the region and we therefore attract and retain the best people.

Hide Ad
Hide Ad

"I want each employee to have the same pride working for B Braun which I have had throughout my career with the company and for them to understand how our products and services make a difference to those who use them.”

Mr Parden continued: “The objective is to achieve mutual growth and guarantee that our company continues to shape, rather than just provide, the healthcare market and deliver substantial value to our customers. B. Braun's partnerships and collaborative efforts with organisations like the NHS will have a significant impact on improving long-term patient outcomes.”

Related topics: